ALNY
Price
$143.31
Change
-$0.40 (-0.28%)
Updated
Apr 26, 6:59 PM EST
5 days until earnings call
OCGN
Price
$1.28
Change
+$0.10 (+8.47%)
Updated
Apr 26, 6:59 PM EST
6 days until earnings call
Ad is loading...

Analysis and predictions ALNY vs OCGN

Header iconALNY vs OCGN Comparison
Open Charts ALNY vs OCGNBanner chart's image
Alnylam Pharmaceuticals
Price$143.31
Change-$0.40 (-0.28%)
Volume$234.53K
CapitalizationN/A
Ocugen
Price$1.28
Change+$0.10 (+8.47%)
Volume$3.23M
CapitalizationN/A
View a ticker or compare two or three
ALNY vs OCGN Comparison Chart

Loading...

ALNYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALNY vs. OCGN commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and OCGN is a Hold.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (ALNY: $143.31 vs. OCGN: $1.28)
Brand notoriety: ALNY and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 68% vs. OCGN: 52%
Market capitalization -- ALNY: $18.12B vs. OCGN: $329.38M
ALNY [@Biotechnology] is valued at $18.12B. OCGN’s [@Biotechnology] market capitalization is $329.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 0 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 0 green, 5 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, OCGN is a better buy in the long-term than ALNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 2 TA indicator(s) are bullish while OCGN’s TA Score has 3 bullish TA indicator(s).

  • ALNY’s TA Score: 2 bullish, 5 bearish.
  • OCGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, OCGN is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -0.76% price change this week, while OCGN (@Biotechnology) price change was -3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2024.

OCGN is expected to report earnings on Aug 02, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALNY with price predictions.
OPEN
A.I.dvisor published
a Summary for OCGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALNY($18.1B) has a higher market cap than OCGN($329M). OCGN YTD gains are higher at: 122.609 vs. ALNY (-25.129).
ALNYOCGNALNY / OCGN
Capitalization18.1B329M5,502%
EBITDAN/AN/A-
Gain YTD-25.129122.609-20%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALNY vs OCGN: Fundamental Ratings
ALNY
OCGN
OUTLOOK RATING
1..100
5479
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
7735
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCGN's Valuation (65) in the null industry is in the same range as ALNY (94) in the Biotechnology industry. This means that OCGN’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (50) in the Biotechnology industry is somewhat better than the same rating for OCGN (100) in the null industry. This means that ALNY’s stock grew somewhat faster than OCGN’s over the last 12 months.

OCGN's SMR Rating (98) in the null industry is in the same range as ALNY (100) in the Biotechnology industry. This means that OCGN’s stock grew similarly to ALNY’s over the last 12 months.

OCGN's Price Growth Rating (35) in the null industry is somewhat better than the same rating for ALNY (77) in the Biotechnology industry. This means that OCGN’s stock grew somewhat faster than ALNY’s over the last 12 months.

OCGN's P/E Growth Rating (100) in the null industry is in the same range as ALNY (100) in the Biotechnology industry. This means that OCGN’s stock grew similarly to ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYOCGN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 6 days ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
ALNYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGIRX50.880.60
+1.19%
Hartford Core Equity R3
OSCYX21.340.12
+0.57%
Invesco Main Street Small Cap Y
MAIRX8.080.04
+0.50%
Victory Trivalent Intl Fd-Core Eq R6
DCUCX13.530.04
+0.30%
DWS CROCI US C
TQMVX17.29-0.01
-0.06%
T. Rowe Price Integrated US LCV Eq

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with OCGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then OCGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.28%
OCGN - ALNY
49%
Loosely correlated
+8.47%
ATRA - ALNY
44%
Loosely correlated
-1.40%
SGMO - ALNY
42%
Loosely correlated
+2.94%
AMLX - ALNY
40%
Loosely correlated
-1.12%
VXRT - ALNY
40%
Loosely correlated
+7.79%
More

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
+8.47%
MDGL - OCGN
51%
Loosely correlated
-0.54%
ARRY - OCGN
47%
Loosely correlated
+3.85%
AXON - OCGN
46%
Loosely correlated
+0.65%
PHAT - OCGN
35%
Loosely correlated
+0.88%
XNCR - OCGN
35%
Loosely correlated
+3.90%
More